In their cohort of high grade meningiomas, most tumors were characterized by NF2 mutations, with very few tumors having mutations in TRAF7, KLF4, AKT1 and SMO, suggesting that high grade meningiomas have few targetable genetic mutations. This evidence concerns the gene SMO and meningioma.